Albendazole
General
- Type: Antiparasitic/Antihelmintic
- Dosage Forms: 200mg
- Common Trade Names:Albenza
Adult Dosing
Indications by Disease
| Disease | Dose | Context |
|---|---|---|
| Acute diarrhea | 400mg PO BID x 21 days | Microsporidium |
| Enterobius | 400mg PO once then repeat in 2 weeks | Adult |
Pediatric Dosing
Indications by Disease
| Disease | Dose | Context |
|---|---|---|
| Enterobius | 400mg PO once then repeat in 2 weeks | Pediatric 2 years or older |
| Enterobius | 200mg PO once then repeat in 2 weeks | Pediatric under 2 years |
Special Populations
- Pregnancy Rating:C
- Lactation: unknown
- Renal Dosing
- Adult: not defined
- Pediatric: not defined
- Hepatic Dosing
- Adult: not defined
- Pediatric: not defined
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
- leukopenia
- neutropenia
- pancytopenia
- acute renal failure
- hepatitis
- SJS
Common
- abnormal LFT's
- abdominal pain
- nausea/vomiting
- headache
- dizziness
- alopecia
- fever
Pharmacology
- Half-life: 8-12 hour
- Metabolism: liver
- Excretion: bile
- Mechanism of Action: inhibits tublin polymerization